Eric Reiman of Banner Alzheimer's Institute awarded Potamkin Prize for Alzheimer's research

The American Academy of Neurology and the American Brain Foundation recently awarded the 2013 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Eric M. Reiman, MD, executive director of Banner Alzheimer's Institute and chief executive officer of Banner Research.

The Potamkin Prize honors researchers for their work in helping to advance the understanding of Pick's disease, Alzheimer's disease and related disorders. The $100,000 prize is an internationally recognized tribute for advancing dementia research. Reiman will receive the award during the Academy's 65th Annual Meeting, March 16-23, 2013, in San Diego.

The Potamkin Prize is being awarded to Reiman for his efforts to characterize some of the earliest brain changes associated with the predisposition to Alzheimer's disease, accelerate the evaluation of promising prevention therapies and help establish the Alzheimer's Prevention Initiative.

"I am grateful for the opportunity to help launch a new era in Alzheimer's prevention research and seek treatments to end this devastating disease without losing another generation," Reiman said. "It has been a privilege to work with my research colleagues, collaborators and other outstanding individuals in the pursuit of our shared goals."

The Potamkin Prize is made possible by the philanthropic contributions of the Potamkin family of Colorado, Philadelphia and Miami. The goal of the prize is to help attract the best medical minds and most dedicated scientists in the world to the field of dementia research. The Potamkin family has been the Academy's single largest individual donor since 1988, providing more than $2.5 million to fund the Potamkin Prize.

Provided by Society for Healthcare Epidemiology of America